Epithelial-to-mesenchymal transition (EMT), a switch of polarized epithelial cells to a migratory, fibroblastoid phenotype, is increasingly considered as an important event during malignant tumor progression and metastasis. To identify molecular players involved in EMT and metastasis, we performed expression profiling of a set of combined in vitro/in vivo cellular models, based on clonal, fully polarized mammary epithelial cells. Seven closely related cell pairs were used, which were modified by defined oncogenes and/or external factors and showed specific aspects of epithelial plasticity relevant to cell migration, local invasion and metastasis. Since mRNA levels do not necessarily reflect protein levels in cells, we used an improved expression profiling method based on polysome-bound RNA, suitable to analyse global gene expression on Affymetrix chips. A substantial fraction of all regulated genes was found to be exclusively controlled at the translational level. Furthermore, profiling of the above multiple cell pairs allowed one to identify small numbers of genes by cluster analysis, specifically correlating gene expression with EMT, metastasis, scattering and/or oncogene function. A small set of genes specifically regulated during EMT was identified, including key regulators and signaling pathways involved in cell proliferation, epithelial polarity, survival and transdifferentiation to mesenchymal-like cells with invasive behavior.
Introduction
Epithelial tumors (carcinomas) comprise more than 80% of all tumors in man. They arise through a multistep process, best studied in human colon cancer and mouse skin tumor progression (Hanahan and Weinberg, 2000) . While many molecular players are known (Christofori and Semb, 1999; Hanahan and Weinberg, 2000) , it remains ill understood as to how oncogenes/tumor suppressors contribute to local invasion and metastasis. However, evidence accumulates that epithelial-to-mesenchymal transition (EMT) represents an important in vitro correlate of late-stage tumor progression (Boyer et al., 2000; Thiery, 2002; Petersen et al., 2003) . During EMT, cells lose epithelial polarity, and acquire a spindle-shaped, highly motile fibroblastoid phenotype. This includes loss or redistribution of tight-and adherens-junction proteins, a switch to a mesenchymal gene-expression program and the ability to pass through the basement membrane (Reichmann et al., 1992; Hay, 1995; Oft et al., 1996) . EMT also occurs during embryonic development, and is regulated by an increasingly complex pattern of signaling pathways (Hay, 1995; Thiery, 2002; Gru¨nert et al., 2003) .
Ras family proteins regulate cell fate and proliferation, cause oncogenic transformation and are mutated/ amplified in a high proportion of human cancers. In multiple epithelial cell models, oncogenic Ras protects cells from transforming growth factor (TGF) b-induced cell cycle arrest and apoptosis. More importantly, Ras cooperates with TGFb to induce EMT, which is stabilized by autocrine production of TGFb (Oft et al., 1996; Lehmann et al., 2000; Gotzmann et al., 2002) . Oncogenic Ras acts through numerous effectors, such as Raf kinase and phosphoinositide 3-OH kinase (PI3-kinase), which trigger the ERK/MAP-and the PKB/ Akt-kinase pathways, respectively (Downward, 1998) . To dissect Ras-downstream signaling with respect to EMT, two Ras effector-specific mutants which predominantly signal either through the ERK/MAPK pathway (S35-V12Ras) or through the PI3K-PKB/AKT pathway (C40-V12Ras; Rodriguez-Viciana et al., 1997) were expressed in polarized mammary epithelial cells (EpH4). Exposure of these cells to TGFb demonstrated that EMT requires hyperactivation of the ERK/MAPK pathway by Ras-S35 while hyperactive PI3K signaling induced by Ras-C40 enabled TGFb-induced 'scattering' in EpH4 cells, a distinct fibroblastoid, migratory phenotype without persistent expression changes in epithelial or mesenchymal markers (Janda et al., 2002a; Gru¨nert et al., 2003) . In addition, Ras-C40 induced protection from TGFb-induced apoptosis and hyperproliferation in 3D collagen gel culture, similar to Ras with an unmutated effector loop, while Ras-S35 caused only moderate apoptosis protection and no hyperproliferation. TGFb-induced scattering is also observed in EpH4 cells protected from apoptosis by overexpression of the antiapoptotic protein Bcl-2 (Janda et al., 2002a, b) .
Injection of the above cells into nude mice showed that hyperactivation of the ERK/MAPK or PI3K pathway but not Bcl-2 overexpression was sufficient to render EpH4 cells tumorigenic. Importantly, metastasis formation required EMT induced by TGFb plus a hyperactivated ERK/MAPK pathway (Janda et al., 2002a) . Finally, activation of a c-Fos-estrogen receptor fusion protein (c-Fos-ER) in EpH4 cells by estradiol caused EMT in vitro, but the cells after EMT were not or weakly tumorigenic in nude or SCID mice, respectively (Reichmann et al., 1992; Eger et al., 2000; Eger, unpublished) .
Together with the fact that TGFb signaling is required for metastasis in vivo (Oft et al., 1998; Muraoka et al., 2002; Yang et al., 2002) , the above results suggest that cooperation of TGFb signaling with distinct Rasdownstream signal transducers determines both the type of epithelial plasticity phenotype induced in culture, and the respective impact on tumor growth and metastatic ability. To determine whether these different epithelial plasticity phenotypes, linked or not linked to metastasis corresponded to distinct gene-expression profiles, potentially yielding EMT/metastasis-specific genes, we employed expression profiling on microarrays (Lockhart et al., 1996) . The aim was to identify genes and/or pathways, whose expression correlates with EMT, scattering, tumor formation or metastasis, also hoping to identify new markers for diagnosis and novel targets for therapeutic intervention. mRNA expression profiling has been successfully used for molecular classification, characterization of tumors, and identification of signaling pathways important for tumor progression in model cell lines (Schulze et al., 2001; van't Veer et al., 2002) . However, the molecular basis of distinct phenotypes of epithelial plasticity in well-defined cellular models and their relevance to late-stage cancer progression were not yet investigated by expression profiling.
A potential drawback of current expression-profiling methods is that total mRNA levels only partially correlate with protein levels (Anderson and Anderson, 1998), due to post-transcriptional regulation. Profiling of polysome-bound mRNA instead of total mRNA significantly reduced the discrepancy between transcriptome and proteome studies (Zong et al., 1999; Mikulits et al., 2000) . In this paper, we successfully applied this method to high-density arrays (Affymetrix), showing that about 15% of all regulated genes were translationally controlled and thus would have been missed by expression profiling of total mRNA. We analysed multiple, EpH4-based sublines, which display distinct aspects of epithelial plasticity relevant for tumorigenicity or metastasis in response to various oncogenes and/ or external signals. Cluster analysis identified regulated genes specifically associated with each of these physiological processes, a surprisingly high fraction of which was translationally regulated. A high proportion of identified genes/pathways, in part verified by protein expression, showed relevance to tumorigenesis/metastasis, including key regulators of cell proliferation and survival, epithelial polarity and motility/invasiveness.
Results

Identification of genes translationally regulated during EMT
To identify new molecular markers and potential key regulators of EMT, we performed a primary screen using total mRNA, polysome-bound mRNA and free mRNA isolated from Ha-Ras-transformed EpH4 cells (EpRas) before and after TGFb-induced EMT (EpRasXT cells). Labeled cRNAs from all samples were individually hybridized to Affymetrix Murine Mu11K arrays, interrogating some 11 000 transcripts. Genes that showed no or minor changes in total mRNA expression in EpRasXT cells as compared to EpRas cells, but whose ratio of polysome-bound versus free mRNA was strongly increased or decreased, were candidates for translationally up-or downregulated genes, respectively. In contrast, transcriptionally regulated mRNAs showed similar up-or downregulation of total, polysome-bound and free mRNA (Figure 1a) .
Analysis of polysome-bound mRNA revealed that 104 transcripts (0.9% of all genes/ESTs on the arrays) were at least fourfold upregulated, while 190 (1.7%) were fourfold downregulated in mesenchymal EpRasXT cells. According to the above criteria, 75% of these 294 genes regulated during EMT were exclusively transcriptionally regulated, 18% showed exclusive regulation on the level of translation, while 7% were regulated on both levels (Table 1) . We then addressed whether regulation of polysome-bound mRNAs listed in Figure 1a correlated with respective protein levels, employing gene products for which specific assays or antibodies were available. The adapter protein Grb7 and the transcriptional repressor Id2 were indeed translationally repressed during EMT, while translational upregulation was verified for the cell adhesion molecule tenascin C and TGFb1, the induction of which is crucial to EMT (Figure 1b, c; R Foisner and A Eger, submitted; Oft et al., 1996) . Other potentially translationally repressed genes included the translational regulator Tristetraproline/Tis11, and a dual-specificity phosphatase acting on MAPK (Figure 1a) . Thus, genome-wide polysome-bound mRNA profiling more faithfully reflected protein amounts than total mRNA levels, as shown before on smaller numbers of genes (Mikulits et al., 2000) .
Classification of genes differentially regulated during EMT
Next, we used a combination of annotation methods to sort all genes regulated in mesenchymal EpRasXT compared to EpRas cells into functional classes (Tables 2 and 3 ). This identified numerous growth factors, receptors, signal transducers, cell adhesion molecules like integrins or ECM proteins, proteases, kinases and transcription factors. Of particular interest was the coregulation of genes that function in particular signaling pathways. Among the sequences induced in mesenchymal cells, we noted a group of genes involved in PDGF/PDGFR signaling, that is, the PDGF-a and PDGF-b receptors, the PDGFactivated signal transducer Stat1 and two known PDGF target genes, the chemokines JE/MCP-1 and KC/Gro1. In all, 11 inflammatory genes responsive to interferon and/or PDGF were upregulated, including the enzyme cyclooxygenase (COX), which plays an To illustrate the shift from free to polysome-bound mRNA or vice versa in translationally controlled genes, the ratio of polysome-bound to free mRNA is also tabulated. As expected, changes in this ratio are much less evident in transcriptionally controlled genes, where total, polysome-bound and free mRNA are up-or downregulated to similar extents. (b) Translational regulation of TGF. mRNA levels (top, determined by RT-PCR, see Eger et al., submitted) and secreted TGFb-levels as measured by ELISA are shown (Oft et al., 1996) in FosER cells before (ÀE2) and after 12 days of estradiol treatment ( þ E2). Note weak (Etwofold) or absent induction of TGFb-1 and -3 mRNA, respectively, while secreted TGFb protein is strongly induced. (c) Verification at the protein level (by Western blot analysis, see Materials and methods) of other genes up-or downregulated with respect to polysome-bound, but not total or free mRNA (see (a)) Total mRNA 3-10-fold regulated, regulation in polysome-bound mRNA 4threefold stronger than in total mRNA
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Many genes typical for mesenchymal/migratory cells such as vimentin, type-III and type-VI collagens, metalloproteases and various ECM proteins were induced (Table 2) . Multiple, in part tissue-specific, transcription factors were downregulated during EMT. Furthermore, genes typical for epithelial cells and known or suspected to be lost during EMT, such as E-cadherin, plakoglobin, occludin, delta-catenin/p120, were strongly downregulated in mesenchymal cells (Table 3) . Taken together, these data confirm that our screen efficiently identifies genes regulated during EMT.
In addition to the translationally regulated genes (Figure 1b , c), we also verified regulation at the protein level for several transcriptionally regulated genes, using either immunofluorescence or Western blot analysis. Several epithelial cell markers downregulated in our screen (E-cadherin, plakoglobin and occludin, see Table 3 ) were no longer detectable in cells after EMT by immunofluorescence (Eger et al., 2000; Janda et al., 2002a , data not shown). Besides vimentin (Janda et al., 2002a) , two new mesenchymal markers (CD68 and Calgranulin A/MRP8 protein, see Table 2 ) were strongly upregulated during EMT, as determined by immunofluorescence (Figure 2a) . Furthermore, components of two signaling pathways found to be activated during EMT (Table 2) could be verified as upregulated in Western blots (Fig 2b) : Stat1, which is subject to activation by the PDGFR pathway, and Dab2, involved in TGFbR signaling and coregulated with the TGFbR coreceptor endoglin and with VLDLR, the latter signaling to Dab1, a close homolog of Dab2 (see below and the Discussion). Finally, real-time PCR and measurements of secreted protein verified upregulation of two further proteins involved in PDGF signaling: the ligand PDGFa and the PDGFR-pathway target gene MCP1 (data not shown).
Gene-expression patterns in cell pairs reflecting distinct types of epithelial plasticity
The above analysis revealed that we identified far too many candidate genes for comprehensive functional characterization. In order to reduce and prioritize the number of candidate genes, we performed comparative expression profiling of multiple cell pairs based on the clonal EpH4 cell line, which was modified by expression of different oncogenes or their mutants, and treated or not treated with TGFb (Figure 3a) . Three cell pairs undergo EMT (EpRas/EpRasXT, EpS35/EpS35-XT; FosERÀ/ þ E2): the former two are tumorigenic with concomitant metastasis formation, while FosER cells are not or weakly tumorigenic (Reichmann et al., 1992; Eger et al., 2000; Janda et al., 2002a; Eger et al., unpublished) .
Two further cell pairs undergo scattering induced by exogenous TGFb, accompanied (EpC40) or not accompanied (EpH4-Bcl-2) by tumor formation (Janda et al., 2002a ; see the introduction and Figure 2a) . Furthermore, we compared the parental EpH4 cells to their counterparts expressing either the Ras-or the Bcl-2 oncogene. EpRas cells differ from EpH4 cells by their tumorigenicity and more variable three-dimensional structures, indicating plastic cell contacts (Oft et al., 1996; Gru¨nert et al., 2003) , while EpH4-Bcl-2 are indistinguishable from EpH4 cells, with the exception of their high protection from apoptotic stimuli (Janda et al., 2002a) . As a more distantly related cell pair, we employed the mesenchymal and highly Expression profiling of epithelial plasticity M Jechlinger et al metastatic colon carcinoma cell line CT26 and its epitheloid derivative CKR, expressing a dominantnegative (dn) TGFbRII. The latter cells are weakly tumorigenic, but lack metastatic potential (Oft et al., 1998) .
Polysome-bound mRNA from all cell pairs was hybridized to Affymetrix Mu11k arrays. Access criteria identified 2225 significantly regulated genes for subsequent hierarchical clustering (see Materials and methods). Results are displayed in a pseudo-color visualization matrix (Figure 3b ). Most strikingly, cell pairs with phenotypically related responses formed a distinct cluster, as cells that have undergone EMT showed similar patterns of gene regulation as compared to their epithelial equivalents (CKR/CT26, EpS35/ EpS35-XT, EpRas/EpRasXT and FosERÀ/ þ E2). Within this branch, the most distantly related cell pair was the colon cancer-derived CKR/CT26, possibly reflecting their different origin. The cell pairs that scatter (EpC40/EpC40XT, EpH4Bcl-2À/ þ TGFb) clustered with the EpH4/EpRas cell pair, in line with their increased plasticity of homotypic adhesion (Oft et al., 1996) . Finally, EpH4 cells expressing HaRas and Bcl-2 formed a separate cluster, probably reflecting oncogenic effects such as protection from apoptosis (see below).
Cluster analysis reveals genes associated with EMT, metastasis formation, scattering and oncogene function Each of the above subgroups of cell pairs was characterized by a striking cluster of upregulated genes, which therefore correlate with scattering, metastatic potential or the expression of oncogenes ( Figure 3b and The fold increases/decreases indicated represent the mean of two pairwise comparisons performed by hybridizing Affymetrix Mu6500 arrays comprising some 6500 genes or ESTs. In order to be included in this list, a threefold regulation of polysome-bound RNA in both comparisons was required. Included in this list are 74 of 88 genes found to be upregulated, and 72 of 98 genes found to be downregulated. Genes that do not fit into these categories, genes with unknown function or ESTs were omitted from this list (Table 4) . Many genes in this group are implicated in cell transformation and tumorigenesis. Examples are the TGFbRIII homolog endoglin, expression of which correlates with bad prognosis in breast cancer, the leucin zipper-type transcription factor ATF-1, translocation of which occurs in malignant melanoma, the zinc-finger transcription factor deltaEF-1 involved in downregulation of the tumor suppressor Ecadherin, the thrombin receptor PAR-1 promoting tumor cell invasion and transformation, and the VLDLR, regulating cell motility in breast cancer cells.
Other genes with a typical EMT signature included DAB2 and the PDGF-inducible CXC chemokine MCP-1, whose expression correlated with a mesenchymal cell phenotype in human cell lines and functions in tissue remodeling and tumor vascularization. Finally, expression of two collagen genes, COL6a1 and COL6a2, closely correlates with EMT, whose expression is atypical for epithelial cells. In contrast, vimentin, a commonly used marker for mesenchymal cells, was massively upregulated in EMT, but also showed a weak upregulation in EpC40 cells during scattering (see Table 4 and supplementary material). We also identified 69 sequences (including 34 known genes) that were specifically downregulated in the cell pairs undergoing EMT. Seven of these encode class II tumor suppressors (Sager, 1997) , which share antiproliferative/anti-invasive properties. Prominent examples are alpha actinin-4, laminin beta 3 and 14-3-3-sigma. Downregulated genes with the EMT signature also included proteins involved in cytoskeletal assembly/ regulation, such as the Flightless I homolog, the 'Huntingtin interacting protein 1-related' and filamin. Figure 3 Gene-expression profiles of different epithelial plasticity phenotypes, using eight 'discriminatory' cell pairs. (a) The eight cell pairs employed for expression profiling (see text) are depicted schematically, reflecting fully or partially polarized epithelial cell types (apical markers, red dots, basolateral markers, green/pink squares) or cells after scattering (retaining epithelial markers) or EMT (acquiring mesenchymal markers, red fibrils). Tumorigenic and metastatic potential of the cells after injection into nude mice is indicated, as well as the type of in vitro epithelial plasticity changes observed in these cells (scattering or EMT; Janda et al., 2002a) . (b) Scaled-down cluster diagram, representing the result of 2D, hierarchical clustering (using the Pearson correlation function), using a set of 2225 genes/ESTs obtained by prefiltering of some 11 000 genes/ ESTs measured across all eight cell pairs. Prefiltering criteria for genes to be included in the 2225 gene/EST set required transcript levels to vary on average at least threefold in two duplicate experiments in at least two of eight cell pairs. The cluster diagram shows a colored representation of the expression data, with the rows (genes) and columns (cell lines) in cluster order. The cellular process dendrogram (top) reflects the correlation coefficients represented by the length of the dendrogram branches connecting pairs of nodes. The dendrogram representing hierarchical relationships between genes was omitted for clarity. The color in each cell of the cluster diagram reflects the meanadjusted fold change of the gene (row) in a respective cell pair (column). Note that cell pairs reflecting related cellular processes cluster tightly together (see bars and description below the cluster diagram). The numbers (#1-8) below the cluster diagram correspond to the numbers assigned to cell pairs in (a). The vertical bars labeled 'scatter', 'oncogene' and 'metastasis' to the right of the cluster diagram refer to some of the clusters of genes shown in detail in Table 4 . The color scale used to represent fold up-(red) or downregulation (blue) of gene expression is depicted in (c). The regulation of many (430) genes identified in this screen has been confirmed by quantitative RT-PCR, Western blot, immunohistochemistry or Northern blot (Eger et al., 2000; Janda et al., 2002a ; data not shown). Many additional genes were confirmed as regulated in an independently performed, suppression-subtractive hybridization (SSH; MJ, unpublished) . No false positives were observed in these experiments; rather, confirmation of regulation often yielded higher levels of induction or repression than determined by the array screen b Expression profiling of epithelial plasticity M Jechlinger et al Table 4 Known genes with distinct molecular signatures Expression profiling of epithelial plasticity M Jechlinger et al (Table 4) . A smaller cluster of 19 known genes and 15 ESTs showed selective upregulation in the EpRas/EpRasXTand EpS35/EpS35XT-cell pairs, correlating with the metastatic potential of these cells. Examples are the metalloproteases Adam19 and MMP-3, the multiple drug-resistance protein ABCB4/MDR3, the hypoxiainducible transcription factor HIF-1a, a master regulator of O 2 homeostasis, as well as amphiregulin, a member of the EGF family. Importantly, metastatic cell pairs upregulated Stat1, which transduces signals mediated by PDGF and interferon/inflammation-related signals (Vignais and Gilman, 1999) . Genes specifically downregulated in cell pairs capable of metastasizing include calveolin-1 (a membrane protein inducing cell cycle arrest in epithelial cells), cathepsin D (a protease previously shown to prevent tumor growth) and Nab2 (a transcriptional repressor that can block Egr-1-mediated angiogenesis).
Two comparatively large clusters were found in cell pairs undergoing scattering (132 known genes and 106 ESTs) and cells expressing the HaRas or Bcl2 oncogenes (110 known genes and 106 ESTs). In the scattering cluster, upregulated genes included several HGF/SFinduced genes, such as RhoA, cortactin and HGFregulated tyrosine kinase substrate, in addition to other regulators of cell motility (calpain 1, integrin-linked kinase, wnt-7b). Finally, in the oncogene cluster, upregulated sequences included many genes involved in various aspects of proliferation (e.g. Cyr61, Gab1, PGK1, PP2A), cell division (e.g. Ran, septin-7, DNA-PK) and genes with antiapoptotic activities (e.g. Bcl-X L , Hsc70, cyclophilin A).
Discussion
An important, novel aspect of this expression-profiling study was the use of multiple EpH4-derived cell pairs, in which different oncoproteins plus external signals cause distinct epithelial plasticity changes correlated with different events in tumor progression. Our approach took advantage of the novel finding that changes in epithelial cells towards migration, can be classified into different plasticity phenotypes, of which only EMT is clearly correlated with metastasis (for a review see Gru¨nert et al., 2003) . Thus, our approach allowed us to assign diverse gene-expression profiles to distinct cellular and molecular processes of interest during early and late carcinogenesis. Inclusion of multiple, well-defined and related cell pairs, differing only by the type of oncogene and/or external factor employed, into our screen avoided the common problem that profiling of single or unrelated cell pairs generally yields numbers of regulated genes far too large to be prioritized for functional analysis by playing obvious key roles in the process under investigation Schulze et al., 2001; Zavadil et al., 2001) . Rather, our approach allowed us to identify small gene clusters exclusively regulated during oncogene activation, scattering, EMT or metastasis formation, effectively narrowing down the number of genes with potential key functions.
Another improvement over standard expression profiling was to adapt polysome-bound mRNA expression profiling to high-density microarrays. So far, this approach has mainly been used to analyse relatively small numbers of preselected genes (Zong et al., 1999; Mikulits et al., 2000) . In our genome-wide screen, about 15% of all regulated transcripts were exclusively translationally controlled during EMT, showing that expression profiling of total mRNA would have missed a significant proportion of regulated genes. In all cases where analysis was possible, protein expression levels closely corresponded to polysome-bound, but not total, mRNA levels (Figure 1b, c) . The same was true for respective profiling of hematopoietic cells (45 genes, Dolznig and von Lindern, unpublished). For cathepsin B (Berquin and Sloane, 1996) and Id2 (Zhang et al., 1995) , translational control (Figure 1 ) was shown previously. Finally, Tristetraprolin/Tis11, which accelerates mRNA degradation in a sequence-specific fashion (Carballo et al., 1998) , is translationally repressed during EMT (Figure 1) , and may thus be involved in the post-transcriptional control of a subset of regulated genes identified in this analysis.
Genes and signaling pathways involved in EMT
Growth factors relevant for cancer: Carcinomas often coexpress multiple growth factors and their receptors, potentially signifying a large variety of autocrine and paracrine loops (de Jong et al., 1998) . Several components of the PDGFR pathway (Table 2, 4) were upregulated during TGFb-induced EMT, suggesting the presence of an overactive PDGF pathway during invasive processes (see Figure 2b and above). Additional studies showed that TGFb induces autocrine production of PDGF during EMT, which appears to be essential in tumor progression and metastasis (Jechlinger et al., in preparation). Our screen also detected selective upregulation of the EGFR family ligand amphiregulin in cell pairs capable of EMT and metastasis (Table 4) . Amphiregulin was one of the most strongly induced genes in Raf-1-ER-expressing human mammary epithelial cells. These cells became fibroblastoid upon estrogen treatment, and established an autocrine amphiregulin/ EGFR loop which protected them from anoikis (Schulze et al., 2001) .
Endoglin, VLDLR, mDab2: At high concentrations, TGFb can inhibit proliferation of epithelial EpRas cells, while mesenchymal EpRasXT cells are not affected (Oft et al., 1996) . This is probably due to different modulation of TGFb signaling before and after EMT. We identified two genes with the EMT signature, endoglin Expression profiling of epithelial plasticity M Jechlinger et al and disabled-2 (DAB-2), which associate with the TGFb receptor complex and modify the intracellular response to TGFb ligands. Endoglin (CD105) is required during embryonic angiogenesis, selectively binds TGFb1/3 and can modulate TGFb signaling by diverting signaling to different receptor complexes (Arthur et al., 2000) . EndoglinÀ/À mice have a phenotype strikingly similar to TGFb1À/À mice. Furthermore, endoglin is the only gene in the TGFbR signaling pathway, the expression of which correlates with bad prognosis in breast cancer patients (Kumar et al., 1999) .
DAB2 is required for efficient phosphorylation of SMAD proteins by the type I receptor (Hocevar et al., 2001) . DAB-2 interacts with Grb2 (Zhou and Hsieh, 2001) and thus also provides a link of TGFbR signaling to the Ras/MapK pathway. DAB-2 and DAB-1 share a highly conserved PDZ domain required for binding to the VLDLR, a component of the reelin receptor complex (D'Arcangelo et al., 1999) . Both the VLDLR and DAB-1 are required for the migration of neurons during brain development (Trommsdorff et al., 1999) . Interestingly, the VLDLR is selectively upregulated in EMT (Table 4) , and known to increase motility in breast cancer cells upon overexpression (Webb et al., 1999) . Thus, the VLDLR might impinge on TGFbR signaling via a VLDLR/DAB-2 complex, and thereby contribute to EMT and metastasis.
Zinc-finger transcription factors repressing E cadherin: A hallmark of human late-stage carcinogenesis is the loss of E-cadherin expression (Christofori and Semb, 1999) . During EMT, E-cadherin is strongly downregulated (Reichmann et al., 1992; Oft et al., 1996) , but only slightly reduced during scattering (Table 4) . Two zincfinger transcription factors (snail, slug) were implicated in EMT-like processes, loss/redistribution of E-cadherin and increased tumorigenicity in carcinoma lines (Nieto et al., 1994; Cano et al., 2000) . While snail was only upregulated in mesenchymal EpRasXT, slug carries the metastasis signature (up in EpRasXT and EpS35-XT cells). A third family member, Zfx1ha/ZEB-1, was most strongly and selectively upregulated in cell pairs undergoing EMT. Interestingly, this factor also binds to the E-cadherin promoter, but has so far not been implicated in EMT.
EMT-specific genes: involvement in late-stage tumorigenesis of human cancers?
A large number of genes exhibiting antiproliferative and/or anti-invasive activity were specifically downregulated in cell pairs undergoing EMT, such as hMSH, 14-3-3 sigma, alpha actinin-4, laminin beta 3 and maspin. Genes like this are also referred to as class II tumor suppressors, since they are not targeted by tumorinitiating mutations but rather downregulated in tumor cells due to altered upstream signaling pathways (Sager, 1997) . NHERF, which interacts with the class II tumor suppressor schwannomin/merlin and plays a critical role in establishing epithelial polarity (Murthy et al., 1998) , was also downregulated during EMT. Furthermore, multiple proteases expressed in migratory, mesenchymal cells were upregulated in EpRasXT cells, while serine protease inhibitors such as the tumor suppressor maspin were strongly reduced (Table 4) . A subset of proteases, including the metalloproteases MMP-3 and ADAM19, were selectively induced in cell pairs with metastatic ability in nude mice, confirming their potential role in tumor progression.
A number of previous reports have attempted to address the metastatic phenotype of tumors using expression-profiling approaches. Importantly, only a limited number of the genes associated with EMT in our study were also revealed in respective studies by others (Perou et al., 1999 Ross et al., 2000; Kiemer et al., 2001; Zavadil et al., 2001; van't Veer et al., 2002) . Ross and colleagues have analysed a number of tumor cell lines, including breast cancer-derived lines, which display very heterogeneous expression patterns, in agreement with other studies. A few genes identified as EMTspecific in our study (Table 4(1a) ; MCP1, DAB2, dihydropyrimidinase-like 3, and Collagen VI) were, however, also found by these authors in cell lines with a 'stromal' or 'mesenchymal' signature (see Figure 5b in Ross et al., 2000) .
Expression profiling of 65 breast tumors, including two matching lymph-node metastases, revealed a number of discernible tumor subtypes , but none of the different molecular phenotypes detected in this study expressed matching genes with the EMT/metastasis signature from our study. Possible explanations for this may be that EMT only occurs in about 20% of breast tumors analysed (Oft et al., 1998) , that no lung metastases were analysed (like those induced by EpRas cells after EMT; Janda et al., 2002a) , that EMT may be a transient process during metastasis, occurring mainly when tumor cells break free of the invasion front (Brabletz et al., 2001) or that tumor cells after EMT (which can resemble normal fibroblasts and express a myofibroblast phenotype; Petersen et al., 2003) are classified as stroma and are thus likely to be missed in macroselected tumor samples.
Another study (Kiemer et al., 2001 ) employed representational difference analysis (RDA) on kidney epithelial cells, in which an EMT-like phenotype was induced by overexpression of mutated E1A. They identified 19 known murine genes as upregulated during EMT. With the exception of vimentin and osteopontin (the latter was found to be upregulated by SSH subtractive hybridization, but was not present on the 11k Affymetrix chip; Jechlinger et al., unpublished), none of these genes overlap with the 40 genes with an EMT signature identified by us (Table 4(1a) and (2a)). This lack of overlap could be explained by the different cell type used (kidney -instead of mammary epithelial cells), by the entirely different oncogene used to induce EMT (mutated E1A instead of Ras), as well as by a possible lack of representativity of the RDA method used.
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Recently, human skin keratinocytes (HACAT) were analysed for expression changes induced by short-term (up to 48 h) TGFb treatment (Zavadil et al., 2001) . These cells undergo scattering instead of EMT (loss of polarity, redistribution of E-cad, no switch to a mesenchymal gene-expression program; for a review see Gru¨nert et al., 2003) . Thus, we neither expected nor found a large overlap with our set of EMT-specific genes. Indeed, only a single gene (peroxisomal membrane protein 3; Table 4(1a)) with an EMT-specific signature was found to be strongly upregulated in these cells after 4 h of TGFb treatment.
In the most interesting study with respect to our set of EMT/metastasis-specific genes, van't Veer et al. (2002) analysed expression profiles of 117 breast tumors. After a 5-year follow-up of the patient's disease history, the tumors were grouped into classes of poor and good prognosis, according to the occurrence of distant metastases, and correlated to the expression profiles of 2029 known genes analysed in these tumors. Strikingly, none of our 40 EMT genes listed in Table 4 (1a) and (2a) correlated with good prognosis in the van't Veer study, while a significant number of EMT-specific genes, which were assessed by van't Veer et al., correlated with poor prognosis (e.g. HIF1a, MCP1; MDR member 2; TNFaIP2; ADAM19; metallothionin 1 and 2; STAT1; vimentin; solute carrier family 1, member 7; and guanylate nucleotide-binding protein 3). This suggests that many genes identified in our study to associate with EMT and metastatic potential in EpRas cells may also be upregulated in human breast tumors prone to distant metastasis. Interestingly, there is also hardly any overlap in genes identified as important for EMT/metastasis between the Kiemer and van 't Veer studies, supporting our idea that the detailed mechanisms leading to EMT in this mutant E1A-driven kidney cell system are quite different.
Outlook: profiling of primary tumors versus combined in vitro/in vivo cell systems
Comparative expression profiling of multiple EpH4 cell models, showing various epithelial plasticity phenotypes and reflecting distinct events during tumor progression in vivo (Janda et al., 2002a, b; Gru¨nert et al., 2003) , allowed one to identify genes and pathways specific for these events. The fact that all cell models were based on one fully polarized, clonal epithelial cell type facilitated the necessary comparisons between them. Similar studies are difficult in primary tumor material. Here, inaccurate tumor cell staging, unknown oncogene/tumor suppressor contribution, unknown extracellular signals, heterogeneity of respective mutations within a tumor and, most importantly, contamination by stromal and immune cells interferes with correct interpretation of expression-profiling results. Our cell culture models thus offer a valuable synergistic approach to expression profiling on primary tumor material, allowing effective cross-verification of candidate genes.
Materials and methods
Cells and cell culture
The origin and culture conditions for EpH4 mouse mammary epithelial cells, their Ha-Ras-transformed derivative EpRas and EpRasXT cells, FosER-expressing EpH4 cells and CT26 colon carcinoma cells expressing or lacking dnTGFbRII were described in Oft et al. (1996 Oft et al. ( , 1998 , Reichmann et al. (1992) and Janda et al. (2002a) . Generation and culture conditions of V12-Ras-, S35-Ras-, C40-Ras-and Bcl-2-expressing EpH4 cells are described in Janda et al. (2002a) . Prior to expressionprofiling analyses, all cell pairs were examined with respect to characteristic epithelial and mesenchymal marker gene expression (Reichmann et al., 1992; Oft et al., 1996) .
Collagen gel culture and immunofluorescence analysis
Serum-free, 3D cultures of EpRas cells and EpRasXT cells were performed as described earlier (Oft et al., 1996 (Oft et al., , 1998 , with minor modifications as described in Janda et al. (2002a) . In situ immunofluorescence analysis followed by confocal microscopy was then performed to visualize staining for Ecadherin, vimentin, Calgranulin A/MRP8 and CD68. The following antibodies were used: polyclonal rabbit anti-Ecadherin (Becton Dickinson, 610182); monoclonal anti-mouse vimentin, Vim-13.4 (Sigma, cat# V-2258), antibody to CD68 (goat polyclonal anti-macrosialin/CD68; Santa Cruz Biotech., sc-7084) and antibody to Calgranulin A/MRP8 (Santa Cruz Biotech., sc-20174).
Western blot analysis
Cell lysates from EpRas and EpRasXT cells were prepared and subjected to Western blot analysis, performed as described earlier (Janda et al., 2002a) . Expression of protein products from translationally regulated genes was analysed in Western blots from EpRas and EpRasXT cells, using antibodies to Grb-7 (Santa Cruz Biotechnologies; N-20), Id-2 (Santa Cruz Biotechnologies; C-20) and Tenascin (a kind gift from G Wirl, Institute of Molecular Biology, Salzburg). Antibodies used to detect the transcriptionally controlled gene products Stat1 and Dab2 in EpRas and EpRasXT cells were from Transduction Laboratories (G-16925) and Santa Cruz Biotech. (sc-7828), respectively. In both analyses, an antibody to Smad 2/3 (Becton Dickinson 610843) served as a loading control.
Sucrose gradient fractionation and RNA analysis
Sucrose gradient fractionation and RNA analysis were performed as described (Mikulits et al., 2000) . From each sucrose gradient, fractions 1-8 (containing free mRNPs and tRNAs) and fractions 11-20 (containing polysome-bound RNAs) were pooled. RNA was purified using the RNeasy kit (Qiagen), treated with DNaseI (Qiagen) and poly(A þ ) mRNA was isolated from these pools using the Roche polyA þ isolation kit. To identify translationally regulated genes, we calculated the fold up-or downregulation of genes identified in total mRNA, polysome-bound mRNA and free mRNA (normalized expression data from at least two parallel Affymetrix chips per cell sample, obtained using Affymetrix's GeneChip s software). Genes in which up-or downregulation factors were similar in total and polysome-bound mRNA were considered as purely transcriptionally regulated. Genes for which polysome-bound mRNA was 4fourfold up-or downregulated, while total mRNA was otwofold regulated and free mRNA was either not or oppositely regulated, were considered as translationally regulated. Finally, genes that showed a 4threefold up-or downregulation in total mRNA while regulation in polysomal mRNA was 4threefold higher (e.g. total mRNA fourfold, polysome-bound mRNA 15-fold upregulated) were considered as being regulated at both the transcriptional and the translational levels.
DNA microarray analysis
Biotin-labeled cRNA for hybridization was prepared as described, using poly(A) þ RNA (Lockhart et al., 1996; Fambrough et al., 1999; Damm et al., 2001) . Fragmented cRNA (10 mg) in 200 ml hybridization solution were hybridized either onto the Affymetrix GeneChip Mu11k array set (sub A, B), representing over 11 000 known murine genes and ESTs, or onto Affymetrix GeneChip Mu6500 probe arrays (sub A-D; 6500 known mouse genes and ESTs). Images were scanned at 3 mm resolution using a Hewlett-Packard GeneArray Scanner, and analysed using Affymetrix GeneChip software. Each of the eight cell pair comparisons were performed at least twice, using separately isolated mRNA preparations derived from independent cellular harvests. Genes showing substantial regulation in an individual cell pair were selected based on the following criteria: (1) exclusion of genes with 'absence calls' in both samples of a pairwise comparison, and (2) a threshold of a threefold change in expression level in each of the two pairwise comparisons. This stringent threshold is based on our observation that very few genes showed a more than threefold change in duplicate control experiments (o1 per 11 000 transcripts on GeneChips were regulated more than threefold in duplicate hybridizations of control samples derived from EpRas cells that were separately harvested and prepared), and effectively eliminates false-positive calls due to technical and sampling variability. For inclusion into cluster analysis, probe sets were required to show regulation according to these defined criteria in at least two of the eight cell pairs analysed, resulting in a new data set of 2225 genes that were subsequently hierarchically clustered (GeneSpring, Silicon Genetics, Redwood City, CA, USA). Hierarchical clustering using the Pearson correlation coefficient as distance metrics was performed using average linkage clustering.
